VEGF Inhibition Study in Ocular Neovascularization (VISION) Clinical Trial Group: Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 113: 992-1001, 2006
Rosenfeld PJ, Brown DM, Heier JS et al: MARINA study group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355: 1419-1431, 2006
Spaide RF, Laud K, Fine HF et al: Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26: 383-390, 2006
Hariprasad SM, Shah GK, Blinder KJ: Short-term intraocular pressure trends following intravitreal pegaptanib (Macugen) injection. Am J Ophthalmol 141: 200-201, 2006
Frenkel REP Mani L, Toler AR et al: Intraocular pressure effects of pegaptanib (Macugen) injections in patients with and without glaucoma. Am J Ophthalmol 143: 1034-1035, 2007